Figure 3

Prevalence of haplotypes at baseline and the first detectable haplotype during the follow-up period for each study participant. Baseline prevalence is indicated by black columns and first follow-up period haplotype detected is indicated by grey columns.* indicates statistically significant difference (p < 0.001; Chi-square) between baseline and follow-up proportion of individuals with no infection.